title: Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage.
abstract: OBJECTIVE
  To evaluate the in vivo effects of hypertonic saline (HTS) resuscitation on the interactions of endothelial cells (ECs) and polymorphonuclear neutrophils (PMNs) and vascular permeability after hemorrhagic shock.
  
  
  BACKGROUND
  The PMN has been implicated in the pathogenesis of EC damage and organ injury following hemorrhagic shock. Compared to Ringer's lactate (RL), HTS resuscitation diminishes PMN and EC adhesion molecule expression and organ sequestration of PMNs.
  
  
  METHODS
  In a murine model of hemorrhagic shock (50 mmHg for 45 minutes followed by resuscitation) using intravital microscopy on cremaster muscle, the authors studied PMN-EC interactions and vascular leakage (epifluorescence after 50 mg/kg fluorescent albumin) in three resuscitation groups: HTS (shed blood + 4 cc/kg 7.5% HTS, n = 12), RL (shed blood + RL [2x shed blood volume], n = 12), and sham (no hemorrhage or resuscitation, n = 9). EC ICAM-1 expression was evaluated by immunohistochemistry. Data, presented as mean +/- SEM, were evaluated by analysis of variance with Bonferroni correction.
  
  
  RESULTS
  There were no differences between groups in flow mechanics. Compared to RL, HTS animals (t = 90 minutes) displayed diminished PMN rolling and PMN adhesion to EC at time intervals beyond t = 0. There were no differences between the sham and HTS groups. Vascular leakage was 45% lower in HTS than in RL-resuscitated animals. Cremaster EC ICAM-1 expression was similar in the two groups.
  
  
  CONCLUSIONS
  Using HTS instead of RL to resuscitate hemorrhagic shock diminishes vascular permeability in vivo by altering PMN-EC interactions. HTS could serve as a novel means of immunomodulation in hemorrhagic shock victims, potentially reducing PMN-mediated tissue injury.
authors.affiliation: Division of General Surgery and Department of Pathology, McGill University Health Center, McGill University, Montréal, Canada.
authors.forename: José L
authors.initials: JL
authors.lastname: Pascual
authors.forename: Lorenzo E
authors.initials: LE
authors.lastname: Ferri
authors.forename: Andrew J E
authors.initials: AJ
authors.lastname: Seely
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Campisi
authors.forename: Prosanto
authors.initials: P
authors.lastname: Chaudhury
authors.forename: Betty
authors.initials: B
authors.lastname: Giannias
authors.forename: David C
authors.initials: DC
authors.lastname: Evans
authors.forename: Tarek
authors.initials: T
authors.lastname: Razek
authors.forename: René P
authors.initials: RP
authors.lastname: Michel
authors.forename: Nicolas V
authors.initials: NV
authors.lastname: Christou
mesh_terms: D000818:Animals; D001783:Blood Flow Velocity; D002199:Capillary Permeability; D002448:Cell Adhesion; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D005440:Fluid Therapy; D018056:Hemorheology; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D009504:Neutrophils / Q000473:pathology / Q000502:physiology*; D012151:Resuscitation; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage*; D012771:Shock, Hemorrhagic / Q000503:physiopathology / Q000628:therapy*
chemical_list: D012462:Saline Solution, Hypertonic; D018799:Intercellular Adhesion Molecule-1